Newstrail.com

Search

Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Investor Notice: Investigation of Takeover by AbbVie Inc

Shareholders_Foundation_Logo

An investigation on behalf of investors, who currently hold shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE), was announced concerning whether the takeover of Cerevel Therapeutics Holdings, Inc. by AbbVie Inc is unfair to NASDAQ: CERE stockholders.

Investors who purchased shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and currently hold any of those NASDAQ: CERE shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm concerns whether certain officers and directors of Cerevel Therapeutics Holdings, Inc. breached their fiduciary duties owed to NASDAQ: CERE investors in connection with the proposed acquisition.

Cambridge, MA based Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. On December 06, 2023, AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) announced an agreement under which AbbVie will acquire Cerevel Therapeutics. Under the terms of the transaction AbbVie Inc. (NYSE: ABBV) will acquire all outstanding Cerevel Therapeutics (NASDAQ: CERE) common stock for $45.00 per share in cash.

However, the investigation concerns whether the offer is unfair to NASDAQ: CERE stockholders. More specifically, the investigation concerns whether the Cerevel Therapeutics Holdings, Inc. Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders’ best interests in connection with the proposed sale.

Those who are current investors in Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

 

Facebook
Twitter
LinkedIn
Pinterest